Response to Levetiracetam in a Patient with Posthypoxic Action Myoclonus
Journal Title: Journal of Neurological Sciences-Turkish - Year 2007, Vol 24, Issue 3
Abstract
Posthypoxic action myoclonus (PAM) can be developed in patients who survived an hypoxic brain injury and is resistant to pharmacological therapy. The patient presented here developed PAM with very serious myoclonic jerks by which he was fully incapacitated. His myocloni did not respond to treatment with most commonly used agents, i.e. valproate, topiramate, clonazepam and baclofen alone or in combination. An important degree of improvement was observed after levetiracetam was started.
Authors and Affiliations
Emine GENC, Serhat TOKGÖZ, Ebru DOGAN, Bulent GENC
Keywords
Related Articles
- EP ID EP144474
- DOI -
- Views 103
- Downloads 0
Harekete İlişkin Kortikal Potansiyallerin Alzheimer Hastalığında Nöröpsikolojik Testler ile Korelasyonu
Harekete ilişkin kortikal potansiyaller (HİKP) bir motor aktivitenin planlanmasını yansıtan yararlı bir yöntemdir. Hareketten önce frontal loblarda maksimum amplitüdde negatif kortikal potansiyal izlenir. Alzheimer hasta...
Cystic Meningioma Imitating Vestibular Schwannoma at the Cerebellopontine Angle: Case Report
Cystic meningioma is a rare type of meningioma which is found mainly in the supratentorial region. The cystic nature of the mass can cause difficulty in the pre-operative diagnosis of these tumours. A 36-year old patient...
Determination of Psychiatric Disorders Among Outpatients Who Admitted to Internal Medicine Clinic in a University Hospital
Objective: Chronic diseases and psychiatric disorders are common health problems. Association of these two chronic processes is an important issue that should be considered in view of general practice. Despite prev...
Controversies and innovations in the new WHO classification of pituitary adenomas
The classification of pituitary tumors is a dynamic area that changes with advances in cell biology that provide a deeper insight and clear understanding of cell lineages and pathogenetic mechanisms. The 2004 edition of...
The Effect of Temozolomide Dose and Erythropoietin Combination On Survivin Gene Expression in Human Glioblastoma Cell Lines
Glioblastoma (GBM) is an aggressive primary brain tumor and it is known that prognosis is poor. Because of the infiltration of the tumor cells to the whole brain tissue, surgery is done for decompression and for histopat...